IDEXX Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. 

CEO
Michael Erickson
CEOMichael Erickson
Employees
11,000
Employees11,000
Headquarters
Westbrook, Maine
HeadquartersWestbrook, Maine
Founded
1983
Founded1983
Employees
11,000
Employees11,000

IDXX Key Statistics

Market cap
44.76B
Market cap44.76B
Price-Earnings ratio
41.46
Price-Earnings ratio41.46
Dividend yield
Dividend yield
Average volume
661.25K
Average volume661.25K
High today
$570.56
High today$570.56
Low today
$553.14
Low today$553.14
Open price
$555.96
Open price$555.96
Volume
160.49K
Volume160.49K
52 Week high
$769.98
52 Week high$769.98
52 Week low
$504.56
52 Week low$504.56

Stock Snapshot

The current IDEXX Laboratories(IDXX) stock price is $567.41, with a market capitalization of 44.76B. The stock trades at a price-to-earnings (P/E) ratio of 41.46.

As of 2026-06-01, IDEXX Laboratories(IDXX) stock has fluctuated between $553.14 and $570.56. The current price stands at $567.41, placing the stock +2.6% above today's low and -0.6% off the high.

The IDEXX Laboratories(IDXX)'s current trading volume is 160.49K, compared to an average daily volume of 661.25K.

During the past year, IDEXX Laboratories(IDXX) stock moved between $504.56 at its lowest and $769.98 at its peak.

During the past year, IDEXX Laboratories(IDXX) stock moved between $504.56 at its lowest and $769.98 at its peak.

IDXX News

Simply Wall St 9h
How Investors May Respond To IDEXX Expanding SDMA and Fecal Dx Integration in Diagnostics

In May 2026, IDEXX Laboratories expanded its Fecal Dx antigen testing to include taeniid tapeworms and integrated the SDMA kidney biomarker into Catalyst CLIPs...

How Investors May Respond To IDEXX Expanding SDMA and Fecal Dx Integration in Diagnostics
Simply Wall St 5d
Is It Time To Reassess IDEXX Laboratories After Recent Share Price Weakness

For investors wondering whether IDEXX Laboratories at around US$557 per share offers fair value or is asking too much for its future potential, this article bre...

Is It Time To Reassess IDEXX Laboratories After Recent Share Price Weakness
TipRanks 6d
Idexx Laboratories expands Fecal Dx platform for taeniid tapeworm detection

IDEXX Laboratories (IDXX) announced the expansion of its Fecal Dx antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Pro...

Analyst ratings

50%

of 16 ratings
Buy
50%
Hold
43.8%
Sell
6.3%

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.